Approximately three times more frequently (OR 2.85–3.05, p < 0.05, Fisher’s exact test) than in other NSCLC subtypes, patients with PSC show an additional, PD-L1-independent immune escape mechanism. This evidence concerns the gene CD274 and non-small cell lung carcinoma.